{ "cik": 1401667, "cik_padded": "0001401667", "entityName": "PUMA BIOTECHNOLOGY, INC.", "fiscal_years": [ { "accn": "0001437749-26-005891", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 71000.0, "cash": 29635000.0, "eps_diluted": 0.61, "free_cash_flow": 41731000.0, "net_income": 31111000.0, "operating_cash_flow": 41802000.0, "operating_income": 37299000.0, "revenue": 228371000.0, "stockholders_equity": 130340000.0, "total_assets": 216302000.0, "total_liabilities": 85962000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6595212521098665, "net_margin": 0.1362300817529371, "operating_margin": 0.16332634178595357, "revenue_growth_yoy": -0.009098877067532152, "roa_avg2y": 0.14482525864978413, "roa_period_end": 0.14383130992778614, "roe_avg2y": 0.27969343492234733, "roe_period_end": 0.23869111554396194 } }, { "accn": "0001437749-26-005891", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 56000.0, "cash": 69219000.0, "eps_diluted": 0.62, "free_cash_flow": 38862000.0, "net_income": 30278000.0, "operating_cash_flow": 38918000.0, "operating_income": 30966000.0, "revenue": 230468000.0, "stockholders_equity": 92125000.0, "total_assets": 213333000.0, "total_liabilities": 121208000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3156906377204884, "net_margin": 0.13137615634274608, "operating_margin": 0.13436138639637607, "revenue_growth_yoy": -0.02193628335108663, "roa_avg2y": 0.13643009861195285, "roa_period_end": 0.1419283467630418, "roe_avg2y": 0.4160008793201756, "roe_period_end": 0.3286621438263229 } }, { "accn": "0001437749-26-005891", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 140000.0, "cash": 84585000.0, "eps_diluted": 0.45, "free_cash_flow": 26869000.0, "net_income": 21591000.0, "operating_cash_flow": 27009000.0, "operating_income": 32640000.0, "revenue": 235637000.0, "stockholders_equity": 53442000.0, "total_assets": 230528000.0, "total_liabilities": 177086000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.313611017551738, "net_margin": 0.09162822476945472, "operating_margin": 0.13851814443402352, "revenue_growth_yoy": 0.03335511399765821, "roa_avg2y": 0.09541148994557952, "roa_period_end": 0.09365890477512492, "roe_avg2y": 0.5753764157228515, "roe_period_end": 0.40400808352980794 } }, { "accn": "0001437749-26-005891", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 76201000.0, "eps_diluted": 0.0, "free_cash_flow": -15827000.0, "net_income": 2000.0, "operating_cash_flow": -15827000.0, "operating_income": 23720000.0, "revenue": 228031000.0, "stockholders_equity": 21608000.0, "total_assets": 222059000.0, "total_liabilities": 200451000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 9.27670307293595, "net_margin": 8.770737312032135e-06, "operating_margin": 0.10402094452070115, "revenue_growth_yoy": -0.09924354644387826, "roa_avg2y": 8.915755030714775e-06, "roa_period_end": 9.006615358981171e-06, "roe_avg2y": 0.00020874647740319382, "roe_period_end": 9.255831173639393e-05 } }, { "accn": "0001437749-25-005496", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 63131000.0, "eps_diluted": -0.72, "free_cash_flow": 20650000.0, "net_income": -29126000.0, "operating_cash_flow": 20650000.0, "operating_income": 1290000.0, "revenue": 253155000.0, "stockholders_equity": -2446000.0, "total_assets": 226585000.0, "total_liabilities": 229031000.0 }, "period_end": "2021-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.11505204321463135, "operating_margin": 0.00509569236238668, "revenue_growth_yoy": 0.12458353693749723, "roa_avg2y": -0.12372850755620692, "roa_period_end": -0.1285433722444116, "roe_avg2y": 6.937239490294153 } }, { "accn": "0001437749-24-006121", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 46000.0, "cash": 85293000.0, "eps_diluted": -1.52, "free_cash_flow": 727000.0, "net_income": -59995000.0, "operating_cash_flow": 773000.0, "operating_income": -30402000.0, "revenue": 225110000.0, "stockholders_equity": -5951000.0, "total_assets": 244220000.0, "total_liabilities": 250171000.0 }, "period_end": "2020-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.2665141486384434, "operating_margin": -0.13505397361290036, "revenue_growth_yoy": -0.17318004848306764, "roa_avg2y": -0.2504356900600052, "roa_period_end": -0.24565965113422325, "roe_avg2y": -10.42303683113273 } }, { "accn": "0001564590-21-009840", "filed": "2023-03-02", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 306000.0, "cash": 60037000.0, "free_cash_flow": 22070000.0, "net_income": -75595000.0, "operating_cash_flow": 22376000.0, "operating_income": -39045000.0, "revenue": 272260000.0, "stockholders_equity": 17463000.0, "total_assets": 234905000.0, "total_liabilities": 217442000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 12.451583347649315, "net_margin": -0.2776573863218982, "operating_margin": -0.14341071035040034, "revenue_growth_yoy": 0.08474009028212166, "roa_avg2y": -0.3060359049201764, "roa_period_end": -0.3218109448500457, "roe_avg2y": -2.9204736425273814, "roe_period_end": -4.328866746836168 } }, { "accn": "0001564590-21-009840", "filed": "2022-03-03", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 439000.0, "cash": 108419000.0, "free_cash_flow": -24544000.0, "net_income": -113575000.0, "operating_cash_flow": -24105000.0, "operating_income": -94655000.0, "revenue": 250991000.0, "stockholders_equity": 34306000.0, "total_assets": 259122000.0, "total_liabilities": 224816000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 6.553255990205795, "net_margin": -0.45250626516488635, "operating_margin": -0.3771250761979513, "revenue_growth_yoy": 8.065956294022033, "roa_avg2y": -0.5349148822433692, "roa_period_end": -0.4383070522765338, "roe_avg2y": -2.5927997443155877, "roe_period_end": -3.3106453681571737 } }, { "accn": "0001564590-21-009840", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 431000.0, "cash": 81698000.0, "free_cash_flow": -172901000.0, "net_income": -291955000.0, "operating_cash_flow": -172470000.0, "operating_income": -292390000.0, "revenue": 27685000.0, "stockholders_equity": 53302000.0, "total_assets": 165525000.0, "total_liabilities": 112223000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 2.10541818318262, "roa_avg2y": -1.395861970046496, "roa_period_end": -1.7638121129738709, "roe_avg2y": -2.2191269581873323 } }, { "accn": "0001564590-20-007591", "filed": "2020-02-28", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4287000.0, "cash": 194494000.0, "free_cash_flow": -145977000.0, "net_income": -276011000.0, "operating_cash_flow": -141690000.0, "operating_income": -276596000.0, "stockholders_equity": 209824000.0, "total_assets": 252790000.0, "total_liabilities": 42966000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2047716181180418, "roa_period_end": -1.0918588551762332, "roe_period_end": -1.3154405597071832 } } ], "latest_filing": { "accn": "0001437749-26-005891", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001401667.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001401667.json" }, "ticker": "PBYI" }